Skip to content

A Cohort Study on Milk Composition, Health Outcomes, and Feeding Practices of Chinese Mothers and Infants

A Cohort Study on Milk Composition, Health Outcomes, and Feeding Practices of Chinese Mothers and Infants

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05235412
Acronym
Phoenix
Enrollment
769
Registered
2022-02-11
Start date
2021-11-19
Completion date
2025-07-31
Last updated
2025-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Feeding, Breast Milk Expression

Brief summary

This is a cohort study to understand the changes of breastmilk composition in the first six months after birth of Chinese infants.

Detailed description

The relationship of breastmilk composition, the maternal gut microbiome and lifestyle factors such as diet, feeding practices and physical activity and the infant's health and gut microbiome will be investigated in this study.

Interventions

OTHERNot applicable: Observational study without any interventions.

Exposures of interest: Maternal diet and lifestyle, demographics, anthropometrics, infant's health outcomes

Sponsors

Danone Nutricia
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Mothers: 1. Generally healthy mothers with the intention to breastfeed. 2. Aged 18 years and above. 3. Written informed consent. Infants: 1. Generally healthy term born (gestational age between 37 and 42 weeks). 2. Breastfed by their mothers, either exclusively or in combination with infant milk formula, at enrolment. 3. Chinese ethnicity of mother and father.

Exclusion criteria

Mothers: 1. Participation in any other studies involving investigational or marketed products concomitantly or two weeks prior to entry into the study. 2. Difficulty to follow up and/or locate (e.g. known transfer to other hospitals, residing outside the city where the study site is located, or planning to move out of the current city; incapability of mothers to comply with study protocol or investigator' s uncertainty about the willingness or ability of the mothers to understand and comply with the protocol requirements. 3. Illegal drug use. 4. Regular smoking and/ or consumption of alcoholic beverages as per investigator's judgement. 5. A BMI of \<18.5 or ≥ 28 pre-pregnancy or during the first regular pregnancy check around or before 16 weeks of gestational age. 6. Acute infectious disease or neoplastic disease or any kind of weakening or debilitating conditions (with history of positive, hepatitis C virus (HCV) or HIV serological test at any time during the pregnancy). 7. Presence of mastitis, fungal infections of the nipple or areola; reactivation of herpes simplex (HSV) or varicella zoster infection in the mammary or thoracic region at the time of enrolment. 8. Presence of chronic diseases such as endocrine, cardiovascular, renal, respiratory or hepatic diseases. 9. Presence of psychosis and severe post-partum depression. 10. Presence of autoimmune disease such as systemic lupus erythematosus, systemic scleroderma, ulcerative colitis, Crohn's disease, celiac disease. 11. Women whose health condition, according to the investigator's judgement, could interfere with the study conduction and assessment. 12. Mothers who have given birth to twins or multiples or infant conceived with Assisted Reproductive Technology (ART). Infants: 1. Participation in any other studies involving investigational or marketed products concomitantly or two weeks prior to entry into the study. 2. At enrolment, any congenital abnormality, chromosomal disorder or severe disease which could interfere with the study conduct and assessment. 3. Consumption of food other than breast milk or infant formula. 4. Fully formula fed at enrolment.

Design outcomes

Primary

MeasureTime frameDescription
Changes in human milk protein concentrationHuman milk samples collected at 1 month, 3 month, 6 months, 12 months, 2 years after infant birthProtein concentration in g/l of human milk will be analyzed
Changes in human milk fat concentrationHuman milk samples collected at 1 month, 3 month, 6 months, 12 months, 2 years after infant birthFat concentration in g/l of human milk will be analyzed
Changes in human milk carbohydrate concentrationHuman milk samples collected at 1 month, 3 month, 6 months, 12 months, 2 years after infant birthCarbohydrate concentration in g/l of human milk will be analyzed
Changes in human milk energy contentHuman milk samples collected at 1 month, 3 month, 6 months, 12 months, 2 years after infant birthEnergy content in kCal/l of human milk will be analyzed
Changes in infant lengthAnthropometrics collected at birth, and 1 month, 3 month, 6 months, 12 months, 2 years after infant birthLength measured in cm
Changes in infant head circumferenceAnthropometrics collected at birth, and 1 month, 3 month, 6 months, 12 months, 2 years after infant birthHead circumference measured in cm
Changes in infant weightAnthropometrics collected at birth, and 1 month, 3 month, 6 months, 12 months, 2 years after infant birthWeight measured in grams

Secondary

MeasureTime frameDescription
Variations in human milk microbiomeHuman milk samples collected at 1 month, 3 month, 6 months, 12 months, 2 years after infant birthAnalyzed by sequencing
Variations in human milk micronutrientsHuman milk samples collected at 1 month, 3 month, 6 months, 12 months, 2 years after infant birthAnalyzed by mass spectrometry
Variations in human milk oligosaccharides (HMOs)Human milk samples collected at 1 month, 3 month, 6 months, 12 months, 2 years after infant birthAnalyzed by mass spectrometry
Variations in human milk lipid compositionHuman milk samples collected at 1 month, 3 month, 6 months, 12 months, 2 years after infant birthAnalyzed by mass spectrometry
Variations in human milk amino acids and proteinsHuman milk samples collected at 1 month, 3 month, 6 months, 12 months, 2 years after infant birthAnalyzed by mass spectrometry
Variations in infant fecal microbiomeInfant fecal samples collected at 1 month, 3 month, 6 months, 12 months, 2 years after infant birthAnalyzed by sequencing
Variations in maternal fecal microbiomeMaternal fecal samples collected at 1 month, 3 month, 6 months, 12 months after infant birthAnalyzed by sequencing
Changes in infant stool consistency and frequencyData collected at 1 month, 3 month, 6 months, 12 months after infant birthData will be collected via diaries using the Brussel Infant and Toddler Stool Scale
Changes in infant feeding practicesData collected at 1 month, 3 month, 6 months, 12 months,2 years after infant birthDietary data will be collected via questionnaires
Changes in maternal body mass indexData collected at 1 month, 3 month, 6 months, 12 months 2 years after infant birthMaternal weight and height will be combined to determine body mass index \[kg/m2\]

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026